Watch
See Our Technology in Action
Discover how JonaTechnologies is transforming cancer care and medical technology delivery across the globe.
JonaTechnologies brings the world's most advanced cancer treatment technologies — from LINAC and Proton Therapy to BNCT and AI-driven diagnostics — to hospitals, governments and research centres across the globe.
Discover how JonaTechnologies is transforming cancer care and medical technology delivery across the globe.
From concept to commissioning — we manage every dimension of advanced medical infrastructure so your team can focus on what matters: patient outcomes.
We design, finance, build and commission complete cancer treatment facilities — including Proton Beam and BNCT centres — for public and private sector clients globally, from bunker design to service delivery.
Learn More →We hold exclusive distribution rights for leading US and European medical imaging and treatment technologies, running a global network across Asia-Pacific, the Middle East and Europe.
Learn More →Strategic planning, financing and project management for governments, hospital groups and international donors — from community diagnostics to advanced radiotherapy installations.
Learn More →Flexible models including straight leasing, co-ownership, pay-per-patient and revenue-sharing — making cutting-edge oncology technology accessible without prohibitive upfront capital.
Learn More →We don't just supply equipment — we build long-term strategic partnerships with institutions ready to lead in cancer care.
Established presence across Asia-Pacific, Europe, South Asia and the Middle East
Exclusive distribution rights for the world's most clinically validated technologies
Turnkey cancer centre projects, equipment installations and advisory mandates
From feasibility study through financing, build, commissioning and ongoing service
All portfolio technologies are FDA cleared, CE marked or equivalent — zero compromise
A curated portfolio of the world's most advanced oncology and medical imaging technologies — each FDA-cleared or CE-marked, each the best in its class.
High-throughput LINAC with optional integrated Gamma Treatment Head. Primary system delivers 6 MV, 120-leaf MLC, 40×40 cm field and 1,400 MU/min — enabling 3D-CRT, IMRT, VMAT, SRS, SBRT and Online-ART. Real-time 3D CBCT and kV/kV imaging with automated intrafractional skull tracking. U.S. FDA 510(k) Cleared. First US patient treated December 2025.
View on Akesis.com →
Xcision
World's first dedicated SRS system for breast cancer. Sub-millimetre precision, prone positioning, and treatment in under 30 minutes — radically reducing radiotherapy from weeks to fractions.
Learn More
TLS / TAE
Next-generation targeted neutron therapy for recurrent head & neck cancers. Selectively destroys tumour cells while sparing surrounding healthy tissue — offering hope where conventional therapy fails.
Learn More
Hyperfine
World's first FDA-cleared portable MRI system. Operates at the patient's bedside on standard wall power — bringing neuroimaging to ICUs, emergency rooms and resource-limited settings globally.
Learn More
LAP
Real-time 3D surface-guided radiation therapy for sub-millimetre patient positioning — eliminating invasive immobilisation for the majority of RT treatments and significantly improving patient comfort.
Learn More
LAP
Comprehensive quality assurance tools for radiation therapy departments — precision lasers, phantoms, patient positioning systems and verification tools trusted by leading cancer centres worldwide.
Learn More
Radformation
Innovate. Automate. Elevate. AI-powered contouring (480+ deep-learning models), automated 3D planning, one-click plan evaluation and independent dose calculation — reducing manual workflow by 80%+.
Learn More
EOS
Low-dose bi-planar full-body 3D skeletal imaging — the global clinical standard for orthopaedic and spinal assessment, surgical planning and patient follow-up in weight-bearing position.
Learn More
Voximetry
Dosimetry-guided radiopharmaceutical therapy assessment software — enabling personalised treatment planning for liver, thyroid and neuroendocrine cancers with patient-specific absorbed dose calculations.
Learn MoreWe partner exclusively with companies that have redefined the standard of care in their fields. Each partnership is built on clinical evidence, regulatory approval and shared commitment to patients.
Akesis
LAP GmbH
Radformation
Our entire portfolio carries the highest regulatory approvals across all major markets — no exceptions, no compromises.
Six offices across three continents, with dedicated clinical, technical and commercial teams embedded in every key market we serve.
Our clinical and application specialists are available to explore how JonaTechnologies can serve your institution — from a single product to a full cancer centre.
Contact Us Today